GPT Healthcare share price, P/E, ROE & financials

On 6 Nov 2026, GPT Healthcare was priced at ₹143.93, or 25.0× trailing earnings, against an industry P/E of 47.7×, and the shares are 18% below their 52-week high. Sales and net profit grew 9.6% and 2.7% a year over 3 years; its ROCE of 16% is the second-highest among the 7 largest Medical Care Facilities peers. Debt is 0.34× equity, and its dividend yield is 2.1%. It is a small-cap company with a market cap of ₹1,181 Cr, ranked 22nd of 40 Medical Care Facilities companies by market cap; the shares fell 3.1% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹147.48
Day high: ₹151.49
Day low: ₹142.53
Prev. close: ₹143.94
Volume: 2.9 L

Health check

3 good · 1 fair · 2 to check

ReturnsBehind
−3.1% over a year, better than 2 of 7 peers.
Price tagCheaper
P/E 25.0 vs industry 47.7.
GrowthSlow
Sales +9.6%, profit +2.7% a year over 3 years.
ProfitabilityAverage
ROCE 16.2% vs peer median 11.9%.
Balance sheetSolid
Debt 0.34× equity, interest covered 8.3×, Piotroski 6 of 9.
Red flagsNone found
No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹1,181 Cr, #22 of 40 in its industry by size.

Defensive

Beta 0.41 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹492 Cr · profit ₹47 Cr

Market cap: ₹1,181 Cr; Small cap
P/E: 25.0; Industry 47.7
Price to book: 4.38; Peers 8.06
Dividend yield: 2.08%
ROE: 16.3%; Peers 12.8%
ROCE: 16.2%; Peers 11.9%
Debt to equity: 0.34; Debt ₹91 Cr
EPS (TTM): ₹5.76; Face value ₹10
OPM (TTM): 18.5%; Net margin 9.6%
Sales growth: +17.8%; Latest quarter vs a year ago
Profit growth: +65.7%; Latest quarter vs a year ago
Price to sales: 2.40; EV/EBITDA 14.9

Strengths

Dividend yield of 2.08%.
Quarterly profit up 65.7% on a year ago.
Quarterly sales up 17.8% on a year ago.
P/E of 25.0 against an industry P/E of 47.7.
Positive operating cash flow in each of the last 4 years.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About GPT Healthcare

GPT Healthcare Limited owns and operates a chain of hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology with renal transplants; laparoscopic and general surgery; critical care; pediatrics; gastroenterology; gynecology and obstetrics; interventional cardiology; orthopedics and joint replacement; neurosciences; and others. It also operates clinics and…

Headquarters: Kolkata
Employees: 2,124
Sector: Healthcare
ISIN: INE486R01017
Website: ilshospitals.com

Price range

52 weeks

₹115.00₹175.00

Today

₹142.53₹151.49

Avg volume (3M): 97.5K
1-year return: minus 3.1%
From 52-week high: minus 17.8%

Peers · Medical Care Facilities

Compare with peers Screen the whole industry

Company
APOLLOHOSPApollo Hospitals Enterprise	8,446.00	plus 0.90%	1,21,441	54.0	11.45	19.2%	22.5%	15.4%	14.8%	33.3%	0.24%	plus 7.2%
MAXHEALTHMax Healthcare Institute	934.00	plus 0.21%	90,909	66.1	8.03	12.6%	12.8%	26.8%	22.4%	9.3%	0.21%	minus 18.1%
MANIPALHOSManipal Health Enterprises	646.70	minus 1.61%	85,065	133.6	9.05	9.8%	9.2%	17.8%	–	–	0.00%	minus 3.0%
ASTERDMAster DM Quality Care	713.15	minus 0.89%	62,092	90.7	8.06	9.4%	9.7%	17.4%	15.7%	−3.0%	0.42%	plus 4.5%
FORTISFortis Healthcare	766.90	minus 6.45%	57,898	55.7	5.52	11.9%	10.4%	22.2%	13.3%	20.9%	0.13%	minus 19.6%
NHNarayana Hrudayalaya	1,903.00	minus 0.65%	38,650	44.7	7.73	11.4%	19.1%	18.5%	20.5%	9.9%	0.24%	plus 4.7%
MEDANTAGlobal Health	1,387.60	minus 0.15%	37,264	60.4	8.63	15.0%	15.2%	22.1%	17.2%	19.5%	0.04%	plus 11.2%
GPTHEALTHGPT Healthcare	143.93	minus 0.01%	1,181	25.0	4.38	16.2%	16.3%	18.5%	9.6%	2.7%	2.08%	minus 3.1%
Median of 7 peers	–	−0.65%	62,092	60.4	8.06	11.9%	12.8%	18.5%	16.5%	14.7%	0.21%	4.5%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
107	119	120	126	126
89.7	96.2	99.5	103	102
17.4	22.7	20.7	23.4	24.2
16.2%	19.1%	17.2%	18.5%	19.2%
1.6	1.3	1.4	1.6	2
1.6	2.2	2.3	2.2	2.2
6.2	6.8	7.1	6.9	6.9
11.1	15.1	12.8	15.9	17.2
30.9%	29.6%	26.6%	8.2%	25.8%
7.7	10.6	9.4	14.6	12.7
0.94	1.29	1.14	1.78	1.55

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: +9.6%
Profit CAGR 3Y: +2.7%
EPS CAGR 3Y: +2.7%
ROE: 16.3%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
358	399	406	472
–	+11.2%	+1.8%	+16.5%
283	308	318	387
75.1	90.6	87.6	85.8
21.0%	22.7%	21.6%	18.2%
3.6	3.5	5.1	4.4
8.4	6.5	2.5	7.5
14.9	18	19	27.1
0.6	−1.5	−1.8	−0.8
56	68	69.3	54.8
30.3%	29.8%	28.0%	23.0%
39	47.8	49.9	42.2
–	+22.5%	+4.5%	minus 15.4%
4.75	5.96	6.08	5.15

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
79.9	82.1	82.1	82.1
85.5	136	166	187
82.4	30.5	35.3	91.2
79	96.5	101	104
327	346	384	465
231	230	277	344
3.4	7	50.3	2.5
5.2	19.2	–	19.3
16.9	19	33.6	47.1
70.5	70.2	23.1	51.7
327	346	384	465

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
66.4	68.8	67.4	81.2
5.2	−25.2	−32.6	−47.3
−73.2	−48.5	−34.8	−31.4
−1.7	−4.9	−0	2.5
−9.9	−19.4	−49.9	−41.8
56.4	49.4	17.5	39.3
−32	−24	−28.7	−20.5

Shareholding pattern

Source: NSE filings

65.6%

promoters

Promoters65.57%
Public34.43%
As of 30 Sep 2026

Quarter	Promoters	Public	Promoter change
30 Sep 2026	65.57%	34.43%	0.00
30 Jun 2026	65.57%	34.43%	0.00
31 Mar 2026	65.57%	34.43%	0.00
31 Dec 2025	65.57%	34.43%	0.00
30 Sep 2025	65.57%	34.43%	–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you